421,639 Shares in DENTSPLY SIRONA Inc. $XRAY Purchased by Nuveen LLC

Nuveen LLC bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 421,639 shares of the medical instruments supplier’s stock, valued at approximately $6,299,000. Nuveen LLC owned 0.21% of DENTSPLY SIRONA at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. lifted its position in DENTSPLY SIRONA by 9.0% during the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock worth $7,391,000 after buying an additional 40,936 shares during the period. Brown Advisory Inc. purchased a new position in DENTSPLY SIRONA during the first quarter worth about $679,000. Comerica Bank lifted its position in DENTSPLY SIRONA by 41.2% during the fourth quarter. Comerica Bank now owns 225,080 shares of the medical instruments supplier’s stock worth $4,272,000 after buying an additional 65,709 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in DENTSPLY SIRONA by 39.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier’s stock worth $805,000 after buying an additional 15,117 shares during the period. Finally, GAMMA Investing LLC lifted its position in DENTSPLY SIRONA by 1,462.9% during the first quarter. GAMMA Investing LLC now owns 99,351 shares of the medical instruments supplier’s stock worth $1,484,000 after buying an additional 92,994 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $14.40 on Tuesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.48. The business has a 50 day moving average price of $15.24 and a two-hundred day moving average price of $15.44. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm has a market cap of $2.87 billion, a PE ratio of -3.04, a price-to-earnings-growth ratio of 0.91 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter last year, the firm earned $0.49 EPS. DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent analyst reports. Wall Street Zen downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Piper Sandler dropped their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, April 30th. Stifel Nicolaus dropped their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research note on Friday, August 8th. Wells Fargo & Company dropped their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Two investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $18.64.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.